Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
67 hedge funds and large institutions have $931M invested in Enfusion, Inc. in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 10 closing their positions.
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
23% more capital invested
Capital invested by funds: $757M → $931M (+$173M)
8% more funds holding
Funds holding: 62 → 67 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$23.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$16.3M |
| 3 |
Millennium Management
New York
|
+$7.27M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.36M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$16.8M |
| 2 |
Bank of New York Mellon
New York
|
-$9.51M |
| 3 |
ACM
Ararat Capital Management
Westport,
Connecticut
|
-$5.39M |
| 4 |
FC
Franchise Capital
Grand Cayman,
Cayman Islands
|
-$4.16M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$1.28M |
ENFN Hedge Fund Activity: Q3 2022 in Review
67 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q3 2022, worth a combined $931M — up 23% from $757M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ENFN positions and 10 closed out — a net gain of 5 holders — while 17 added to existing stakes and 22 trimmed.
The largest buyer was Brown Capital Management, adding an estimated $23.8M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $16.8M sold.
- 67 institutional investors held Enfusion, Inc. (ENFN) as of Q3 2022, up from 62 in Q2 2022.
- Funds reported $931M of Enfusion, Inc. stock for Q3 2022, up 23% quarter-over-quarter.
- 15 funds opened new Enfusion, Inc. positions in Q3 2022 and 10 closed out, a net change of +5 holders.
- The largest Enfusion, Inc. buyer in Q3 2022 was Brown Capital Management, an estimated $23.8M added.
- The largest Enfusion, Inc. seller in Q3 2022 was TimesSquare Capital Management, an estimated $16.8M sold.
Based on aggregated 13F filings for Q3 2022.